Jiangsu Haici Biological Pharmaceutical

Jiangsu Haici Biological Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and large-scale production of high-end active pharmaceutical ingredients (APIs) and finished dosage forms. The company focuses on several key therapeutic areas, including cardiovascular diseases, oncology, and the central nervous system. With a strong emphasis on quality management and international standards, Haici operates advanced manufacturing facilities in the Haimen High-tech Zone of Nantong. Their product portfolio includes generic versions of widely used drugs such as Apixaban, Rivaroxaban, and Lenvatinib. The company serves both domestic and international markets, positioning itself as a reliable partner in the global pharmaceutical supply chain. Haici is committed to technological innovation and maintains a robust R&D pipeline aimed at bringing affordable, high-quality medications to patients worldwide.